Trial Site Detail
Drug: |
AT13387 |
|||
|---|---|---|---|---|
Trial: |
Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Completed |
|||
Beth Israel Deaconess Medical Center330 Brookline Ave. |
Principal Investigator: |
Bruce Dezube M.D. |
|---|---|
Contact: |
Sue Gotthardt RN, OCN (617) 632-9272 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Beth Israel Deaconess Medical Center Website: |
http://www.bidmc.org/Research/Departments/Medicine/Divisions/HematologyOncology/PhaseIInvestigationalGroup.aspx |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.